Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-Hodgkin's lymphoma

Nissim Haim, Menachem Ben-Shahar, David Faraggi, Avital Tsuri-Etzioni, Michelle Leviov, Ron Epelbaum

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences